Delivery Order SPE2DB22D1202-SPE2DB25FVLL4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $4,705.66. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competed award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No small business...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $1,055.25. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $3,943.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes. This non-set-aside contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,018.19, is for the supply of 4,567,448,573 units of 2 mg/2 mL naloxone syringes. The order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4 mg/10 mL vials on July 11, 2025, with a contract ceiling value of $10,276.45. This firm fixed price delivery order, with an ultimate completion date of July 14, 2025, represents a competitively awarded non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be...
- The Defense Logistics Agency awarded a $2,093.64 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone 0.4 mg/mL in vial format. The contract, which represents no set-aside designation, is scheduled for completion by June 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLL4Delivery Order
The Defense Logistics Agency awarded a $2,159.74 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Naloxone 2 mg/2 mL syringes. The contract is a firm fixed price delivery order with a completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation, reflecting the vendor's capability to meet federal medical supply requirements in open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies numerous therapeutic categories including specialty medications, generic and brand-name drugs, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/16/25 |